Research Highlights


Compound may ease spinal-cord damage

October 15, 2008

Neurobiologists at the Kansas City (Mo.) VA Medical Center found that rats given a certain compound after sustaining a spinal cord injury had 50 percent less tissue damage in the spine than control rats. The experimental drug, which inhibits a gene called caspase-3, also enabled better functional recovery. The authors, led by Bruce Citron, PhD, suggest that “caspase-3 inhibition may be a viable therapy in the early hours” after spinal cord injury and that their results "may have significant implications for emergency management of human spinal cord injury." (Spine, Oct. 2008)